The Zambia Medicines and Medical Supplies Agency (ZAMMSA) says the country has maintained a robust supply of Anti-Retroviral (ARV) drugs to meet patient demand.
ZAMMSA Senior Corporate Communications Officer, Enoch Lusoke, says the agency has over six months’ supply of first, second, and third-line ARV drugs, ensuring that all patients undergoing Anti-Retroviral Treatment (ART) receive their necessary medications without interruption.
In a statement issued to RCV News today, Mr. Lusoke has assured the public that there is no current or impending shortage of ARVs and has urged for calmness, as the supply and distribution of the essential medication is stable.
“Healthcare facilities that may have experienced temporary shortages are urged to submit emergency orders for restocking to ensure uninterrupted services to the community,” said Mr. Lusoke
He further said the agency is committed to the efficient procurement, storage, and distribution of vital health commodities.
By Melissa Zaza
